Adrienne Nedved

The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice

Sameer A. Parikh, Sara J. Achenbach, Timothy G. Call et al. · Cancer Medicine · 2020 · 53 citations · Full text

Real-World Outcomes with Bispecific T-Cell Engagers (REALBiTE) for Relapsed or Refractory Large B-Cell Lymphoma: A Multi-Center, Retrospective Cohort Study

Taylor Brooks, Emily C. Zabor, Yohana B. Bedelu et al. · Blood · 2024 · 13 citations

Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outcomes

Charlotte B Wagner, Kenneth M. Boucher, Adrienne Nedved et al. · Haematologica · 2023 · 12 citations · Full text

Comparison of outcomes in postinduction strategies for primary central nervous system lymphoma: a Mayo Clinic experience

Steven R. Hwang, Richard Godby, Brianna J. Negaard et al. · Blood Advances · 2025 · 12 citations · Full text

Clinical Treatment Guidelines for Tafasitamab plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Adrienne Nedved, Kami J. Maddocks, Grzegorz S. Nowakowski · The Oncologist · 2023 · 10 citations · Full text